Ptpn11基因编码非受体型蛋白酪氨酸磷酸酶SHP-2(src同源区域2结构域磷酸酶-2),在细胞增殖、分化、存活和死亡中发挥着关键作用。SHP-2参与下游的RAS-MAPK和JAK/STAT信号传导事件,与多种疾病相关,包括Noonan综合征(NS)、Noonan综合征伴多发痣(NSML)等。这些疾病具有多种表型,包括听力障碍、颅面畸形、身材矮小、先天性心脏缺陷、皮肤疾病、眼科学异常和癌症易感性等。Ptpn11基因突变可导致SHP-2功能异常,进而影响相关信号传导途径,导致上述疾病的发生。
Noonan综合征是一种常见的常染色体显性遗传病,主要特征为面部特征性畸形、身材矮小和先天性心脏缺陷等。Ptpn11基因突变是Noonan综合征的主要原因之一,约50%的病例由Ptpn11基因突变引起。Ptpn11基因突变导致SHP-2功能增强,进而影响RAS-MAPK信号传导途径,导致Noonan综合征的发生。研究发现,Ptpn11基因突变患者的表型存在较大的异质性,包括先天性心脏异常、身材矮小、胸壁畸形、隐睾症和发育迟缓等。此外,Ptpn11基因突变还与Chiari I畸形和脊髓空洞症等神经系统疾病有关[1][2][3][4][5][7][8]。
Ptpn11基因突变在先天性心脏病(CHD)的发生中也发挥重要作用。研究发现,Ptpn11基因突变与CHD的发病风险增加有关,尤其是房间隔缺损(ASD)亚型。Ptpn11基因突变通过影响RAS-MAPK信号传导途径中相关蛋白的磷酸化水平,进而影响心肌细胞的增殖和迁移能力,导致CHD的发生[2]。
Ptpn11基因突变还与听力障碍有关。研究发现,Ptpn11基因突变患者的听力损失主要表现为中重度损害,且异常的内耳和听神经也是其特征之一。此外,Ptpn11基因突变患者的听力损失类型多样,包括单侧或双侧听力丧失等[4][6]。
Ptpn11基因突变与多种疾病的发生和发展密切相关,包括Noonan综合征、先天性心脏病和听力障碍等。深入研究Ptpn11基因突变的作用机制,有助于为相关疾病的治疗和预防提供新的思路和策略。此外,Ptpn11基因突变的研究还有助于深入理解RNA表观遗传修饰的生物学功能和疾病发生机制,为疾病的治疗和预防提供新的思路和策略。
参考文献:
1. Tartaglia, Marco, Kalidas, Kamini, Shaw, Adam, Patton, Michael A, Gelb, Bruce D. 2002. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. In American journal of human genetics, 70, 1555-63. doi:. https://pubmed.ncbi.nlm.nih.gov/11992261/
2. Xu, Zi-Qing, Chen, Wei-Cheng, Li, Yu-Jie, Sheng, Wei, Huang, Guo-Ying. 2022. PTPN11 Gene Mutations and Its Association with the Risk of Congenital Heart Disease. In Disease markers, 2022, 8290779. doi:10.1155/2022/8290779. https://pubmed.ncbi.nlm.nih.gov/35440950/
3. Athota, Jeevana Praharsha, Bhat, Meenakshi, Nampoothiri, Sheela, Farooque, Mohammed Oomer, Shetty, Swathi. 2020. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations. In BMC medical genetics, 21, 50. doi:10.1186/s12881-020-0986-5. https://pubmed.ncbi.nlm.nih.gov/32164556/
4. Xu, H Y, Yuan, Y Y, Dai, P. . [PTPN11 and the deafness]. In Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery, 33, 830-834. doi:10.13201/j.issn.1001-1781.2019.09.008. https://pubmed.ncbi.nlm.nih.gov/31446698/
5. Yi, Zhi, Xue, Jiao, Song, Zhenfeng, Yang, Chengqing, Zhang, Ying. 2024. A patient with a PTPN11 gene variant complicated with Chiari I malformation and syringomyelia and a review of literatures. In International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 85, e10396. doi:10.1002/jdn.10396. https://pubmed.ncbi.nlm.nih.gov/39653642/
6. Wu, Xionghui, Huang, Min, Huang, Weiqing, Liu, Guangliang, Chang, Shuting. 2023. Preliminary investigation of the diagnosis and gene function of deep learning PTPN11 gene mutation syndrome deafness. In Frontiers in genetics, 14, 1113095. doi:10.3389/fgene.2023.1113095. https://pubmed.ncbi.nlm.nih.gov/36760995/
7. Turner, Anne M. 2011. Noonan syndrome. In Journal of paediatrics and child health, 50, E14-20. doi:10.1111/j.1440-1754.2010.01970.x. https://pubmed.ncbi.nlm.nih.gov/21771153/
8. Zepeda-Olmos, Paola Montserrat, Esparza-García, Eduardo, Robles-Espinoza, Kiabeth, Rodríguez Gutiérrez, Perla Graciela, Magaña-Torres, María Teresa. 2024. Variants of the PTPN11 Gene in Mexican Patients with Noonan Syndrome. In Genes, 15, . doi:10.3390/genes15111379. https://pubmed.ncbi.nlm.nih.gov/39596579/